These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36056568)

  • 21. Surfactant replacement therapy. New levels of understanding.
    Holm BA
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):834-6. PubMed ID: 8214936
    [No Abstract]   [Full Text] [Related]  

  • 22. Initial Observations on the Effect of Repeated Surfactant Dose on Lung Volume and Ventilation in Neonatal Respiratory Distress Syndrome.
    Kallio M; van der Zwaag AS; Waldmann AD; Rahtu M; Miedema M; Papadouri T; van Kaam AH; Rimensberger PC; Bayford R; Frerichs I
    Neonatology; 2019; 116(4):385-389. PubMed ID: 31505498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants.
    Farrell EE; Silver RK; Kimberlin LV; Wolf ES; Dusik JM
    Am J Obstet Gynecol; 1989 Sep; 161(3):628-33. PubMed ID: 2675599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy.
    Rubin BK; Ramirez O; King M
    Chest; 1992 Apr; 101(4):1080-5. PubMed ID: 1555424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Noninvasive Surfactant Adsorption Test Predicting the Need for Surfactant Therapy in Preterm Infants Treated with Continuous Positive Airway Pressure.
    Autilio C; Echaide M; Benachi A; Marfaing-Koka A; Capoluongo ED; Pérez-Gil J; De Luca D
    J Pediatr; 2017 Mar; 182():66-73.e1. PubMed ID: 27989413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimally invasive surfactant therapy for moderate to late premature neonates with respiratory distress syndrome born in a non-tertiary unit.
    Tinoco Mendoza G; Allgood C; Tan A
    J Paediatr Child Health; 2021 Oct; 57(10):1658-1661. PubMed ID: 34021656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll R; Wiswell TE
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surfactant Injury in the Early Phase of Severe Meconium Aspiration Syndrome.
    Autilio C; Echaide M; Shankar-Aguilera S; Bragado R; Amidani D; Salomone F; Pérez-Gil J; De Luca D
    Am J Respir Cell Mol Biol; 2020 Sep; 63(3):327-337. PubMed ID: 32348683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid and surfactant delivery into pulmonary airways.
    Halpern D; Fujioka H; Takayama S; Grotberg JB
    Respir Physiol Neurobiol; 2008 Nov; 163(1-3):222-31. PubMed ID: 18585985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent clinical trials of surfactant treatment for neonates.
    Halliday HL
    Biol Neonate; 2006; 89(4):323-9. PubMed ID: 16770072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface tension of airway aspirates withdrawn during neonatal resuscitation reflects lung maturity.
    Stichtenoth G; Walter G; Lange R; Raith M; Bernhard W; Herting E
    Pediatr Pulmonol; 2014 Aug; 49(8):751-6. PubMed ID: 24106079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Techniques to evaluate surfactant activity for a personalized therapy of RDS neonates.
    Autilio C
    Biomed J; 2021 Dec; 44(6):671-677. PubMed ID: 34758409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surfactant replacement therapy for preterm and term neonates with respiratory distress.
    Polin RA; Carlo WA; ;
    Pediatrics; 2014 Jan; 133(1):156-63. PubMed ID: 24379227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
    Dunn MS; Shennan AT; Zayack D; Possmayer F
    Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural surfactant instilled in premature lambs increases lung volume and improves ventilation homogeneity within five minutes.
    Vilstrup C; Gommers D; Bos JA; Lachmann B; Werner O; Larsson A
    Pediatr Res; 1992 Nov; 32(5):595-9. PubMed ID: 1480463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular aspects of pulmonary surfactant in neonatal respiratory distress syndrome and surfactant replacement therapy].
    Chida S; Fujiwara T
    Nihon Rinsho; 1996 Feb; 54(2):346-52. PubMed ID: 8838080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasonic nebulized in comparison with instilled surfactant treatment of preterm lambs.
    Henry MD; Rebello CM; Ikegami M; Jobe AH; Langenback EG; Davis JM
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):366-75. PubMed ID: 8756808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant use for neonatal lung injury: beyond respiratory distress syndrome.
    Finer NN
    Paediatr Respir Rev; 2004; 5 Suppl A():S289-97. PubMed ID: 14980286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.